EMITF Stock Elbit Imaging (EMITF, $2.1) was a top quarterly gainer, rising +55.56%

GET DAILY SIGNALS

Get AI intraday signals

EMITF - Elbit Imaging, Ltd.

Loading...

Price: $2.1

Daily change: -$0.03 (-1.41%)

Daily volume: 1.5K

3-month price change: +$0.75 (+55.56%)

Capitalization: $23.9M

Industry: Medical Specialties

Elbit Imaging (EMITF, $2.1) was one of top quarterly gainers, jumping +5 to $2.1 per share. A.I.dvisor analyzed 411 stocks in the Medical Specialties Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.

Momentum Indicator for EMITF turns positive, indicating new upward trend

EMITF saw its Momentum Indicator move above the 0 level on November 19, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator turned positive. In of the 52 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for EMITF just turned positive on November 24, 2025. Looking at past instances where EMITF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

EMITF moved below its 50-day moving average on November 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EMITF crossed bearishly below the 50-day moving average on November 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.023) is normal, around the industry mean (29.760). P/E Ratio (0.000) is within average values for comparable stocks, (181.462). Dividend Yield (0.041) settles around the average of (0.028) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (578.788).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EMITF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMITF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.